Clinical pharmacologist, Prof. Stefan Russmann, discussed the latest scientific evidence supporting PGx-guided pharmacotherapy and presented first-hand experience with implementing pharmacogenetics in clinical decision-making.
Prof. Stefan Russmann, Clinical Pharmacologist, founder of drugsafety.ch, and Senior Consulting Physician, Hirslanden Hospital Group, Switzerland
Dr. Robin Everts, Senior Manager for Scientific Affairs and Global Pharmacogenetics & Clinical Genetics Lead, Agena Bioscience
Recorded on Tuesday, November 30th, 2021
Learn more about our pharmacogenetics solutions.